期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

高血压患者不同体位醛固酮/血浆肾素活性值比较 被引量：4

Comparison of aldosterone/plasma rennin activity ratio among hypertension patients in different posture
原文传递
导出
摘要 目的对高血压患者卧位和立位的醛固酮/血浆肾素活性值(ARR)进行分析,探讨同一患者2种不同体位时ARR值的差异。方法应用放射免疫测定120例患者血浆肾素活性(PRA)和醛固酮(ALD),分别在卧位和立位采血测定血浆PRA和ALD,计算ARR值后进行分析。结果120例患者的卧位ARR值为(153.14±33.25),立位ARR值为(78.80±27.42)。样本ARR值经对数转换后符合正态分布。按α=0.05进行配对t检验,t=7.218,P<0.05,认为卧位和立位ARR对数值的分布差异有统计学意义。结论ARR值在立位和卧位时存在差异,应制定适用于不同体位的诊断标准。 Objective To determine and compare the activities of aldosterome and plasma rennin among hypertention patients in lying and standing position.Methods The blood samples were collected from hypertention patients in lying and standing position,respectively.The radioimmunoassay was used to detect plasma rennin activity（PRA） and plasma aldos-terone（ALD）.And the plasma aldosterone/rennin activity ratio（ARR） was calculated.Results The values of ARR were 153.14±33.25 for 120 patients in lying position and 78.80±27.42 for 120 patients in standing position with significant differece in pared-samples T-test（t=7.218,P0.05）.Conclusion There is a difference in ARR values between hypertention patients in lying and standing position and the difference should be considered when ARR value is used in diagnosis.
作者 张炯 邹恒昀 徐顺清 舒柏华
机构地区 华中科技大学同济医学院公共卫生学院环境医学研究所教育部环境与健康重点实验室
出处 《中国公共卫生》 CAS CSCD 北大核心 2010年第3期262-263,共2页 Chinese Journal of Public Health
基金 国家自然科学基金(200777022)
关键词 高血压 体位 醛固酮/血浆肾素活性比值(ARR) hypertension posture plasma aldosterone/rennin activity ratio（ARR）
分类号 R544.1 [医药卫生—心血管疾病] R181.36 [医药卫生—流行病学]
  • 相关文献

参考文献5

二级参考文献33

  • 1Abdelhamid S,Muller-Lobeck H,Pahl S,et al.Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients.Arch Intern Med,1996,156:1190-1195.
  • 2Kaplan NM.Resistant hypertension.Hypertension,2005,23:1441-1444.
  • 3Lorena M,Cristian C,Alexis G,et al.Primary aldosteronism.Hypertension,2003,42:161-165.
  • 4Hiramatsu K,Yamada T,Yukimura Y,et al.A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity.Results in hypertensive patients.Arch Intern Med,1981,141:1589-1593.
  • 5Fardella CE,Mosso L,Gomez-Sanchez C,et al.Primary hyperaldosteronism in essential ypertensives:prevalence,biochemical profile,and molecular biology.J Clin Endocrinol Metab,2000,85:1863-1867.
  • 6Mulatero P,Stowasser M,Loh KC,et al.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents.J Clin Endocrinol Metab,2004,89:1045-1050.
  • 7Nishizaka MK,Pratt-Ubunama M,Zaman MA,et al.Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.Am J Hypertens,2005,18:805-812.
  • 8Ferrari P,Shaw SG,Nicod J,et al.Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.Hypertension,2004,22:377-381.
  • 9Oliviero O,Ciacciarelli A,Signorelli D,et al.Aldosterone to rennin ratio in a primary care settings:the Bussolengo study.J Clin Endocrinol Metab,2004,89:4221-4226.
  • 10Hirohara D,Nomura K,Okmoto K,et al.Performance of the Basal aldosterone to renin ratio and of the renin Stimulation Test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives.J Clin Endocrinol Metab,2001,86:4292-4298.

共引文献54

同被引文献32

  • 1陈绍行,杜月凌,张瑾,龚艳春,胡亚蓉,初少莉,何清波,宋艳艳,朱鼎良.在高血压患者中筛选原发性醛固酮增多症国人血浆醛固酮/肾素活性比值标准的探讨[J].中华心血管病杂志,2006,34(10):868-872. 被引量：48
  • 2Hiramatsu K, Yamada T, Yukimura Y, et al. A screening test to identify aldosterone producing adenoma by measuring plasma re- nin activity. Results in hypertensive patients [J]. Arch Intern Med, 1981,141(12) : 1589-1593.
  • 3Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients[J]. J Am Coil Cardiol, 2006,48 (11):2293-2300.
  • 4Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents[J]. J Clin Endocrinol Metab,2004,89 (3) :1045-1050.
  • 5Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment[J].Arch Intern Med, 2008,168 (1) : 80-85.
  • 6Funder JW, Carey RM, Fardella C, et al. Case detection, diag- nosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2008,93(9) :3266-3281.
  • 7Letavernier E, Peyrard S, Amar L, et al. Blood pressure out- come of adrenalectomy in patients with primary hyperaldosteron- ism with or without unilateral adenoma[J]. JHypertens, 2008,26 (9) : 1816-1823.
  • 8Tiu SC, Choi CH, Shek CC, et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling [J].J Clin Endocrinol Metab,2005,90(1) :72-78.
  • 9Funder JW, Carey RM. , Fardella C, Gomez-Sanchez CE, Man- tero F, Stowasser M, Young WF Jr, Montori VM. Case detec- tion, diagnosis, and treatment of patients with primary aldoste- ronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2008, 93 (9): 3266-3281.
  • 10Galati SJ. Primary aldosteronism; challenges in diagnosis and management. Endocrinol Metab Clin North Am, 2015, 44 (2) : 355-369.

引证文献4

二级引证文献34

中国公共卫生
2010年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部